Co-Diagnostics, Inc.
CODX
$0.2981
-$0.002-0.67%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -66.31% | -27.84% | |||
| Total Other Revenue | -- | -100.00% | |||
| Total Revenue | -66.31% | -76.71% | |||
| Cost of Revenue | -91.53% | -14.22% | |||
| Gross Profit | 127.15% | -130.75% | |||
| SG&A Expenses | -48.32% | 24.13% | |||
| Depreciation & Amortization | -21.48% | 1.68% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -28.65% | 10.85% | |||
| Operating Income | 28.18% | -16.34% | |||
| Income Before Tax | 31.87% | -14.11% | |||
| Income Tax Expenses | 246.34% | -136.94% | |||
| Earnings from Continuing Operations | 31.71% | -13.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 31.71% | -13.76% | |||
| EBIT | 28.18% | -16.34% | |||
| EBITDA | 28.38% | -16.86% | |||
| EPS Basic | 34.20% | -12.36% | |||
| Normalized Basic EPS | 30.51% | -17.39% | |||
| EPS Diluted | 33.11% | -12.13% | |||
| Normalized Diluted EPS | 30.51% | -17.39% | |||
| Average Basic Shares Outstanding | 3.80% | 1.25% | |||
| Average Diluted Shares Outstanding | 3.80% | 1.25% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||